| Significant CODM expense categories |
The table below summarizes the significant expense categories regularly provided to, and reviewed by, the CODM for the three and six months ended June 30, 2026 and 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical and manufacturing |
|
$ |
1,812 |
|
|
$ |
184 |
|
|
$ |
2,484 |
|
|
$ |
373 |
|
|
Other research and development |
|
|
1,028 |
|
|
|
714 |
|
|
|
2,016 |
|
|
|
1,035 |
|
|
Total research and development |
|
|
2,840 |
|
|
|
898 |
|
|
|
4,500 |
|
|
|
1,408 |
|
|
General and administrative |
|
|
1,610 |
|
|
|
684 |
|
|
|
3,746 |
|
|
|
1,396 |
|
|
Loss from operations |
|
|
(4,450 |
) |
|
|
(1,582 |
) |
|
|
(8,246 |
) |
|
|
(2,804 |
) |
|
Other expense, net |
|
|
52 |
|
|
|
309 |
|
|
|
10 |
|
|
|
796 |
|
|
Total other expense, net |
|
|
52 |
|
|
|
309 |
|
|
|
10 |
|
|
|
796 |
|
|
Net loss |
|
$ |
(4,502 |
) |
|
$ |
(1,891 |
) |
|
$ |
(8,256 |
) |
|
$ |
(3,600 |
) |
|
|